← Back to Patent Explorer
US6358277B1 Expired / Lapsed US ⏱️ 0.0 years remaining

Atrio-ventricular valvular device

Assignee: International Heart Institute of Montana Foundation
•
Filing: 2000-06-21
•
Granted: 2002-03-19
•
Expires: 2020-06-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An anatomically designed atrioventricular valve is made of biologically compatible synthetic membrane or biological membrane of autologous, homologous or heterologous origin. A single piece of the selected membrane material is trimmed so as to form two unequal sheaths similar to the normal anterior and posterior mammalian mitral valve leaflets with a wide upper base to be sutured to the host's mitral annulus. These two leaflets are prolonged and tapered into two thin bands to be connected to the papillary muscles serving as replacements for the natural marginal chordae tendinae of the normal mitral valve. The two lateral sides of the membrane are joined to form a truncated cone with a wider upper circular base and a narrow extremity formed by the thin chordal bands. A set of sutures are placed between selected points at the base of the cone and the two thin prolongations serving as replacements for the strut or stay basal chords of the natural mitral valve. Thus, the mitral valve prosthesis is anatomical because it is stentless, bicuspid and supported by marginal and basal chordae. Obturators and sizers in the configuration of rods of varying diameter, to measure the host's valve annulus diameter and select the appropriate size of the prosthesis are used during implantation of the prosthesis. A rod shaped holder maintains the prosthesis during implantation, and a curved bodied measuring instrument is used to determine the precise location where the chordae tendinae of the prosthesis are to be sutured to the papillary muscles of a recipient mammal.

Inventors

  • 👤 Carlos M. G. Duran

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 04:28
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2496; A61F2/2412; A61F2/2442; A61F2/2454; A61F2/2457

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 268 words
A stentless heart valve prosthesis to be used for the replacement of a diseased atrioventricular valve in the heart of a recipient mammal, comprising: a single unitary body of biologically acceptable non-absorbable flexible membrane configured substantially in the shape of an anatomically correct mitral valve, the membrane forming a hollow inverted truncated cone having a substantially circular base forming an annulus at its first end, said base forming annulus corresponding to the mitral annulus of the heart of the recipient and configured and adapted for suturing into the mitral annulus of the heart of the recipient, the membrane further forming an anterior and posterior leaflet configured substantially in the form of the anterior and posterior leaflets of the natural mitral valve of the heart of the recipient, and the membrane still further forming two narrow extensions at its second end opposite to the annulus where the inverted cone is narrower than at its first end, the extensions substantially configured as anatomically correct cords and adapted to be sutured to the papillary muscle of the heart of the recipient, and two lines of biologically acceptable non-absorbable material, the lines configured and positioned as substantially anatomically correct strut cords of the natural mitral valve, each of said lines being affixed at one end substantially to the base of the truncated cone and at a second end substantially to the extremity of one of the extensions, respectively, whereby after implantation into the heart of the recipient the anterior and posterior leaflets of the prosthesis collapse during systole and form a plurality of scallops in substantial simulation of a natural mitral valve.
Claim 2
Dependent Claim 268 words
A stentless heart valve prosthesis to be used for the replacement of a diseased atrioventricular valve in the heart of a recipient mammal, comprising: a single unitary body of biologically acceptable non-absorbable flexible membrane configured substantially in the shape of an anatomically correct mitral valve, the membrane forming a hollow inverted truncated cone having a substantially circular base forming an annulus at its first end, said base forming annulus corresponding to the mitral annulus of the heart of the recipient and configured and adapted for suturing into the mitral annulus of the heart of the recipient, the membrane further forming an anterior and posterior leaflet configured substantially in the form of the anterior and posterior leaflets of the natural mitral valve of the heart of the recipient, and the membrane still further forming two narrow extensions at its second end opposite to the annulus where the inverted cone is narrower than at its first end, the extensions substantially configured as anatomically correct cords and adapted to be sutured to the papillary muscle of the heart of the recipient, and two lines of biologically acceptable non-absorbable material, the lines configured and positioned as substantially anatomically correct strut cords of the natural mitral valve, each of said lines being affixed at one end substantially to the base of the truncated cone and at a second end substantially to the extremity of one of the extensions, respectively, whereby after implantation into the heart of the recipient the anterior and posterior leaflets of the prosthesis collapse during systole and form a plurality of scallops in substantial simulation of a natural mitral valve.
Claim 3
Dependent Claim 36 words
A heart valve prosthesis in accordance with claim 1 wherein each line configured as a strut cord is shorter than the total distance between the base of the prosthesis and the extremity of the respective extension.
Claim 4
Dependent Claim 35 words
A heart valve prosthesis in accordance with claim 1 wherein the membrane forming the truncated cone includes one suture along its length in the axial direction, the suture joining together the anterior and posterior leaflets.
Claim 5
Dependent Claim 18 words
A heart valve prosthesis in accordance with claim 3 wherein the membrane consists essentially of biocompatible synthetic material.
Claim 6
Dependent Claim 18 words
A heart valve prosthesis in accordance with claim 3 wherein the membrane consists essentially of biocompatible biological material.
Claim 7
Dependent Claim 23 words
A heart valve prosthesis in accordance with claim 5 wherein the biological material of the membrane is of autologous, homologous or heterologous origin.
Claim 8
Dependent Claim 37 words
A heart valve prosthesis in accordance with claim 1 wherein the membrane forming the truncated cone includes one suture along its length in the axial direction, the suture joining together two substantial halves of the posterior leaflet.
Claim 9
Dependent Claim 18 words
A heart valve prosthesis in accordance with claim 7 wherein the membrane consists essentially of biocompatible synthetic material.
Claim 10
Dependent Claim 18 words
A heart valve prosthesis in accordance with claim 7 wherein the membrane consists essentially of biocompatible biological material.
Claim 11
Dependent Claim 23 words
A heart valve prosthesis in accordance with claim 9 wherein the biological material of the membrane is of autologous, homologous or heterologous origin.
Claim 12
Dependent Claim 45 words
A heart valve prosthesis in accordance with claim 1 wherein a biologically acceptable reinforcing member is attached to the extremity of each one of the extensions whereby sutures attaching the extensions to the papillary muscle of the heart of the recipient have a reinforced base.
Claim 13
Dependent Claim 290 words
A stentless heart valve prosthesis to be used for the replacement of a diseased atrioventricular valve in the heart of a recipient mammal, comprising: a single unitary body of biologically acceptable non-absorbable flexible membrane configured substantially in the shape of an anatomically correct mitral valve, the membrane forming a hollow inverted truncated cone having a substantially circular base forming an annulus at its first end, said base forming annulus corresponding to the mitral annulus of the heart of the recipient and configured and adapted for suturing into the mitral annulus of the heart of the recipient, the membrane further forming an anterior and posterior leaflet configured substantially in the form of the anterior and posterior leaflets of the natural mitral valve of the heart of the recipient, and the membrane still further forming two narrow extensions at its second end opposite to the annulus where the inverted cone is narrower than at its first end, the extensions substantially configured as anatomically correct cords and adapted to be sutured to the papillary muscle of the heart of the recipient, and two lines of biologically acceptable non-absorbable material, the lines configured and positioned as substantially anatomically correct strut cords of the natural mitral valve, each of said lines being affixed at one end substantially to the base of the truncated cone and at a second end substantially to the extremity of one of the extensions, respectively, and each line being shorter than the total distance between the base of the prosthesis and the extremity of the respective extension whereby after implantation into the heart of the recipient the anterior and posterior leaflets of the prosthesis collapse during systole and form a plurality of scallops in substantial simulation of a natural mitral valve.
Claim 14
Dependent Claim 290 words
A stentless heart valve prosthesis to be used for the replacement of a diseased atrioventricular valve in the heart of a recipient mammal, comprising: a single unitary body of biologically acceptable non-absorbable flexible membrane configured substantially in the shape of an anatomically correct mitral valve, the membrane forming a hollow inverted truncated cone having a substantially circular base forming an annulus at its first end, said base forming annulus corresponding to the mitral annulus of the heart of the recipient and configured and adapted for suturing into the mitral annulus of the heart of the recipient, the membrane further forming an anterior and posterior leaflet configured substantially in the form of the anterior and posterior leaflets of the natural mitral valve of the heart of the recipient, and the membrane still further forming two narrow extensions at its second end opposite to the annulus where the inverted cone is narrower than at its first end, the extensions substantially configured as anatomically correct cords and adapted to be sutured to the papillary muscle of the heart of the recipient, and two lines of biologically acceptable non-absorbable material, the lines configured and positioned as substantially anatomically correct strut cords of the natural mitral valve, each of said lines being affixed at one end substantially to the base of the truncated cone and at a second end substantially to the extremity of one of the extensions, respectively, and each line being shorter than the total distance between the base of the prosthesis and the extremity of the respective extension whereby after implantation into the heart of the recipient the anterior and posterior leaflets of the prosthesis collapse during systole and form a plurality of scallops in substantial simulation of a natural mitral valve.
Claim 15
Dependent Claim 35 words
A heart valve prosthesis in accordance with claim 12 wherein the membrane forming the truncated cone includes one suture along its length in the axial direction, the suture joining together the anterior and posterior leaflets.
Claim 16
Dependent Claim 24 words
A heart valve prosthesis in accordance with claim 13 wherein the membrane consists essentially of biocompatible biological material of autologous, homologous or heterologous origin.
Claim 17
Dependent Claim 45 words
A heart valve prosthesis in accordance with claim 14 wherein a biologically acceptable reinforcing member is attached to the extremity of each one of the extensions whereby sutures attaching the extensions to the papillary muscle of the heart of the recipient have a reinforced base.
Claim 18
Dependent Claim 37 words
A heart valve prosthesis in accordance with claim 12 wherein the membrane forming the truncated cone includes one suture along its length in the axial direction, the suture joining together two substantial halves of the posterior leaflet.
Claim 19
Dependent Claim 24 words
A heart valve prosthesis in accordance with claim 16 wherein the membrane consists essentially of biocompatible biological material of autologous, homologous or heterologous origin.
Claim 20
Dependent Claim 43 words
A heart valve prosthesis in accordance with claim 17 wherein the extremity of each of the extensions comprises a double layer of biological membrane whereby sutures attaching the extensions to the papillary muscle of the heart of the recipient have a reinforced base.

References Cited (Backward Citations)

US3739402A Cited
US4790844A Cited
US5156621A Cited
US4960424A Cited
US5415667A Cited
US5344442A Cited
US5500015A Cited
US5733331A Cited
US5824067A Cited
WO1999066967A1 Cited
US6214055B1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2005-03-18 2005-09-17 2006-03-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2009-03-18 2009-09-17 2010-03-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2013-03-18 2013-09-17 2014-03-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag